Blood loss and the rating of the lesion. The values are reported as median (1st/3rd quartiles) or mean (sd). Group SR, sevoflurane/remifentanyl group; Group PR, propofol/remifentanyl group; NRS, numeric rating scale for surgical condition (0, best; 10, worst); High LM score, LM score >12; Low LM score, LM score ≤12. †Data from two patients with high LM score in group SR were excluded because their anaesthetic method was changed to propofol/remifentanyl anaesthesia during operation. *P<0.01. **P<0.05. §P<0.01 with other three groups. §§P<0.05 with other three groups
. | Group SR (n=18†) . | Group PR (n=20) . | ||
---|---|---|---|---|
. | Low LM score (n=7) . | High LM score (n=11) . | Low LM score (n=9) . | High LM score (n=11) . |
Blood loss (ml h−1) | 128 (37/154)* | 19 (10/55) | ||
17 (6/128) | 135 (121/222)§ | 19 (12/57) | 19 (8/71) | |
NRS | 4.8 (2.4)** | 2.9 (1.6) | ||
3.0 (1.5) | 5.8 (2.3)§§ | 3.4 (2.0) | 2.3 (1.0) |
. | Group SR (n=18†) . | Group PR (n=20) . | ||
---|---|---|---|---|
. | Low LM score (n=7) . | High LM score (n=11) . | Low LM score (n=9) . | High LM score (n=11) . |
Blood loss (ml h−1) | 128 (37/154)* | 19 (10/55) | ||
17 (6/128) | 135 (121/222)§ | 19 (12/57) | 19 (8/71) | |
NRS | 4.8 (2.4)** | 2.9 (1.6) | ||
3.0 (1.5) | 5.8 (2.3)§§ | 3.4 (2.0) | 2.3 (1.0) |
Blood loss and the rating of the lesion. The values are reported as median (1st/3rd quartiles) or mean (sd). Group SR, sevoflurane/remifentanyl group; Group PR, propofol/remifentanyl group; NRS, numeric rating scale for surgical condition (0, best; 10, worst); High LM score, LM score >12; Low LM score, LM score ≤12. †Data from two patients with high LM score in group SR were excluded because their anaesthetic method was changed to propofol/remifentanyl anaesthesia during operation. *P<0.01. **P<0.05. §P<0.01 with other three groups. §§P<0.05 with other three groups
. | Group SR (n=18†) . | Group PR (n=20) . | ||
---|---|---|---|---|
. | Low LM score (n=7) . | High LM score (n=11) . | Low LM score (n=9) . | High LM score (n=11) . |
Blood loss (ml h−1) | 128 (37/154)* | 19 (10/55) | ||
17 (6/128) | 135 (121/222)§ | 19 (12/57) | 19 (8/71) | |
NRS | 4.8 (2.4)** | 2.9 (1.6) | ||
3.0 (1.5) | 5.8 (2.3)§§ | 3.4 (2.0) | 2.3 (1.0) |
. | Group SR (n=18†) . | Group PR (n=20) . | ||
---|---|---|---|---|
. | Low LM score (n=7) . | High LM score (n=11) . | Low LM score (n=9) . | High LM score (n=11) . |
Blood loss (ml h−1) | 128 (37/154)* | 19 (10/55) | ||
17 (6/128) | 135 (121/222)§ | 19 (12/57) | 19 (8/71) | |
NRS | 4.8 (2.4)** | 2.9 (1.6) | ||
3.0 (1.5) | 5.8 (2.3)§§ | 3.4 (2.0) | 2.3 (1.0) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.